Coexpression analysis showed that FOXL2 and miR‐133b were negatively correlated in NSCLC patient samples in the TCGA database (https://portal.gdc.cancer.gov) (Figure 5C, Figure S4). Here, FOXL2 is linked to non-small cell lung carcinoma.